Article
Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma.
Neuro-oncology - 1 May 2012
Tykocinski Elana S, Grant Ryan A, Kapoor Gurpreet S, Krejza Jaroslaw, Bohman Leif-Erik, Gocke Timothy A, Chawla Sanjeev, Halpern Casey H, Lopinto Joanna, Melhem Elias R, O'Rourke Donald M
Abstract excerpt
Identification of the epidermal growth factor receptor variant III (EGFRvIII) mutation in glioblastoma has become increasingly relevant in the optimization of therapy. Traditionally, determination of tumor EGFRvIII-expression has relied on tissue-based diagnostics. Here, we assess the accuracy of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.